Industry: Chemical & Material
Published Date: 2025-02-14
Pages: 83 Pages
Report ld: 3808554
Request Sample
Customized Report
The global market for Pharmaceutical Grade Methyl Isonicotinate was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
In the field of medicine, methyl isonicotinate can be used as a strong vasodilator in the treatment of cardiovascular, bronchial and other diseases. It also has good antiviral activity and cancer cell inhibition, and can be used in the treatment of cancer and AIDS.
North American market for Pharmaceutical Grade Methyl Isonicotinate was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Pharmaceutical Grade Methyl Isonicotinate was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Pharmaceutical Grade Methyl Isonicotinate was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global key companies of Pharmaceutical Grade Methyl Isonicotinate include Alfa Aesar, DOW, Pharmaffiliates, SimSon Pharma Limited, Meryer (Shanghai) Chemical Technology Co., Ltd., etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Grade Methyl Isonicotinate, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Pharmaceutical Grade Methyl Isonicotinate by region & country, by Type, and by Application.
The Pharmaceutical Grade Methyl Isonicotinate market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Grade Methyl Isonicotinate.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Pharmaceutical Grade Methyl Isonicotinate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Pharmaceutical Grade Methyl Isonicotinate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Pharmaceutical Grade Methyl Isonicotinate in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Pharmaceutical Grade Methyl Isonicotinate Product Introduction
1.2 Global Pharmaceutical Grade Methyl Isonicotinate Market Size Forecast
1.2.1 Global Pharmaceutical Grade Methyl Isonicotinate Sales Value (2020-2031)
1.2.2 Global Pharmaceutical Grade Methyl Isonicotinate Sales Volume (2020-2031)
1.2.3 Global Pharmaceutical Grade Methyl Isonicotinate Sales Price (2020-2031)
1.3 Pharmaceutical Grade Methyl Isonicotinate Market Trends & Drivers
1.3.1 Pharmaceutical Grade Methyl Isonicotinate Industry Trends
1.3.2 Pharmaceutical Grade Methyl Isonicotinate Market Drivers & Opportunity
1.3.3 Pharmaceutical Grade Methyl Isonicotinate Market Challenges
1.3.4 Pharmaceutical Grade Methyl Isonicotinate Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Pharmaceutical Grade Methyl Isonicotinate Players Revenue Ranking (2024)
2.2 Global Pharmaceutical Grade Methyl Isonicotinate Revenue by Company (2020-2025)
2.3 Global Pharmaceutical Grade Methyl Isonicotinate Players Sales Volume Ranking (2024)
2.4 Global Pharmaceutical Grade Methyl Isonicotinate Sales Volume by Company Players (2020-2025)
2.5 Global Pharmaceutical Grade Methyl Isonicotinate Average Price by Company (2020-2025)
2.6 Key Manufacturers Pharmaceutical Grade Methyl Isonicotinate Manufacturing Base and Headquarters
2.7 Key Manufacturers Pharmaceutical Grade Methyl Isonicotinate Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Pharmaceutical Grade Methyl Isonicotinate
2.9 Pharmaceutical Grade Methyl Isonicotinate Market Competitive Analysis
2.9.1 Pharmaceutical Grade Methyl Isonicotinate Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Pharmaceutical Grade Methyl Isonicotinate Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Grade Methyl Isonicotinate as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 98% Purity
3.1.2 99% Purity
3.2 Global Pharmaceutical Grade Methyl Isonicotinate Sales Value by Type
3.2.1 Global Pharmaceutical Grade Methyl Isonicotinate Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Pharmaceutical Grade Methyl Isonicotinate Sales Value, by Type (2020-2031)
3.2.3 Global Pharmaceutical Grade Methyl Isonicotinate Sales Value, by Type (%) (2020-2031)
3.3 Global Pharmaceutical Grade Methyl Isonicotinate Sales Volume by Type
3.3.1 Global Pharmaceutical Grade Methyl Isonicotinate Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Pharmaceutical Grade Methyl Isonicotinate Sales Volume, by Type (2020-2031)
3.3.3 Global Pharmaceutical Grade Methyl Isonicotinate Sales Volume, by Type (%) (2020-2031)
3.4 Global Pharmaceutical Grade Methyl Isonicotinate Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Cardiovascular Diseases
4.1.2 Bronchial Disease
4.1.3 Cancer
4.1.4 Other
4.2 Global Pharmaceutical Grade Methyl Isonicotinate Sales Value by Application
4.2.1 Global Pharmaceutical Grade Methyl Isonicotinate Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Pharmaceutical Grade Methyl Isonicotinate Sales Value, by Application (2020-2031)
4.2.3 Global Pharmaceutical Grade Methyl Isonicotinate Sales Value, by Application (%) (2020-2031)
4.3 Global Pharmaceutical Grade Methyl Isonicotinate Sales Volume by Application
4.3.1 Global Pharmaceutical Grade Methyl Isonicotinate Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Pharmaceutical Grade Methyl Isonicotinate Sales Volume, by Application (2020-2031)
4.3.3 Global Pharmaceutical Grade Methyl Isonicotinate Sales Volume, by Application (%) (2020-2031)
4.4 Global Pharmaceutical Grade Methyl Isonicotinate Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Pharmaceutical Grade Methyl Isonicotinate Sales Value by Region
5.1.1 Global Pharmaceutical Grade Methyl Isonicotinate Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Pharmaceutical Grade Methyl Isonicotinate Sales Value by Region (2020-2025)
5.1.3 Global Pharmaceutical Grade Methyl Isonicotinate Sales Value by Region (2026-2031)
5.1.4 Global Pharmaceutical Grade Methyl Isonicotinate Sales Value by Region (%), (2020-2031)
5.2 Global Pharmaceutical Grade Methyl Isonicotinate Sales Volume by Region
5.2.1 Global Pharmaceutical Grade Methyl Isonicotinate Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Pharmaceutical Grade Methyl Isonicotinate Sales Volume by Region (2020-2025)
5.2.3 Global Pharmaceutical Grade Methyl Isonicotinate Sales Volume by Region (2026-2031)
5.2.4 Global Pharmaceutical Grade Methyl Isonicotinate Sales Volume by Region (%), (2020-2031)
5.3 Global Pharmaceutical Grade Methyl Isonicotinate Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Pharmaceutical Grade Methyl Isonicotinate Sales Value, 2020-2031
5.4.2 North America Pharmaceutical Grade Methyl Isonicotinate Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Pharmaceutical Grade Methyl Isonicotinate Sales Value, 2020-2031
5.5.2 Europe Pharmaceutical Grade Methyl Isonicotinate Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Pharmaceutical Grade Methyl Isonicotinate Sales Value, 2020-2031
5.6.2 Asia Pacific Pharmaceutical Grade Methyl Isonicotinate Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Pharmaceutical Grade Methyl Isonicotinate Sales Value, 2020-2031
5.7.2 South America Pharmaceutical Grade Methyl Isonicotinate Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Pharmaceutical Grade Methyl Isonicotinate Sales Value, 2020-2031
5.8.2 Middle East & Africa Pharmaceutical Grade Methyl Isonicotinate Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Pharmaceutical Grade Methyl Isonicotinate Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Pharmaceutical Grade Methyl Isonicotinate Sales Value
6.2.1 Key Countries/Regions Pharmaceutical Grade Methyl Isonicotinate Sales Value, 2020-2031
6.2.2 Key Countries/Regions Pharmaceutical Grade Methyl Isonicotinate Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Pharmaceutical Grade Methyl Isonicotinate Sales Value, 2020-2031
6.3.2 United States Pharmaceutical Grade Methyl Isonicotinate Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Pharmaceutical Grade Methyl Isonicotinate Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Pharmaceutical Grade Methyl Isonicotinate Sales Value, 2020-2031
6.4.2 Europe Pharmaceutical Grade Methyl Isonicotinate Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Pharmaceutical Grade Methyl Isonicotinate Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Pharmaceutical Grade Methyl Isonicotinate Sales Value, 2020-2031
6.5.2 China Pharmaceutical Grade Methyl Isonicotinate Sales Value by Type (%), 2024 VS 2031
6.5.3 China Pharmaceutical Grade Methyl Isonicotinate Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Pharmaceutical Grade Methyl Isonicotinate Sales Value, 2020-2031
6.6.2 Japan Pharmaceutical Grade Methyl Isonicotinate Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Pharmaceutical Grade Methyl Isonicotinate Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Pharmaceutical Grade Methyl Isonicotinate Sales Value, 2020-2031
6.7.2 South Korea Pharmaceutical Grade Methyl Isonicotinate Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Pharmaceutical Grade Methyl Isonicotinate Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Pharmaceutical Grade Methyl Isonicotinate Sales Value, 2020-2031
6.8.2 Southeast Asia Pharmaceutical Grade Methyl Isonicotinate Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Pharmaceutical Grade Methyl Isonicotinate Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Pharmaceutical Grade Methyl Isonicotinate Sales Value, 2020-2031
6.9.2 India Pharmaceutical Grade Methyl Isonicotinate Sales Value by Type (%), 2024 VS 2031
6.9.3 India Pharmaceutical Grade Methyl Isonicotinate Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Alfa Aesar
7.1.1 Alfa Aesar Company Information
7.1.2 Alfa Aesar Introduction and Business Overview
7.1.3 Alfa Aesar Pharmaceutical Grade Methyl Isonicotinate Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Alfa Aesar Pharmaceutical Grade Methyl Isonicotinate Product Offerings
7.1.5 Alfa Aesar Recent Development
7.2 DOW
7.2.1 DOW Company Information
7.2.2 DOW Introduction and Business Overview
7.2.3 DOW Pharmaceutical Grade Methyl Isonicotinate Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 DOW Pharmaceutical Grade Methyl Isonicotinate Product Offerings
7.2.5 DOW Recent Development
7.3 Pharmaffiliates
7.3.1 Pharmaffiliates Company Information
7.3.2 Pharmaffiliates Introduction and Business Overview
7.3.3 Pharmaffiliates Pharmaceutical Grade Methyl Isonicotinate Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Pharmaffiliates Pharmaceutical Grade Methyl Isonicotinate Product Offerings
7.3.5 Pharmaffiliates Recent Development
7.4 SimSon Pharma Limited
7.4.1 SimSon Pharma Limited Company Information
7.4.2 SimSon Pharma Limited Introduction and Business Overview
7.4.3 SimSon Pharma Limited Pharmaceutical Grade Methyl Isonicotinate Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 SimSon Pharma Limited Pharmaceutical Grade Methyl Isonicotinate Product Offerings
7.4.5 SimSon Pharma Limited Recent Development
7.5 Meryer (Shanghai) Chemical Technology Co., Ltd.
7.5.1 Meryer (Shanghai) Chemical Technology Co., Ltd. Company Information
7.5.2 Meryer (Shanghai) Chemical Technology Co., Ltd. Introduction and Business Overview
7.5.3 Meryer (Shanghai) Chemical Technology Co., Ltd. Pharmaceutical Grade Methyl Isonicotinate Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Meryer (Shanghai) Chemical Technology Co., Ltd. Pharmaceutical Grade Methyl Isonicotinate Product Offerings
7.5.5 Meryer (Shanghai) Chemical Technology Co., Ltd. Recent Development
8 Industry Chain Analysis
8.1 Pharmaceutical Grade Methyl Isonicotinate Industrial Chain
8.2 Pharmaceutical Grade Methyl Isonicotinate Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Pharmaceutical Grade Methyl Isonicotinate Sales Model
8.5.2 Sales Channel
8.5.3 Pharmaceutical Grade Methyl Isonicotinate Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Pharmaceutical Grade Methyl Isonicotinate was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-02-02
Pages: 89
USD 3950.00
(Single User License)
The global Pharmaceutical Grade Methyl Isonicotinate market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-02-02
Pages: 123
USD 2900.00
(Single User License)
The global Pharmaceutical Grade Methyl Isonicotinate market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-03
Pages: 113
USD 4900.00
(Single User License)
The global Pharmaceutical Grade Methyl Isonicotinate market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-14
Pages: 71
USD 4250.00
(Single User License)
The global market for Pharmaceutical Grade Methyl Isonicotinate was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-14
Pages: 80
USD 2900.00
(Single User License)
In the field of medicine, methyl isonicotinate can be used as a strong vasodilator in the treatment of cardiovascular, bronchial and other diseases. It also has good antiviral activity and cancer cell inhibition, and can be used in the treatment of cancer and AIDS.
Published Date: 2024-04-14
Pages: 93
USD 4900.00
(Single User License)
The global market for Pharmaceutical Grade Methyl Isonicotinate was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-02-02
Pages: 89
The global Pharmaceutical Grade Methyl Isonicotinate market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-02-02
Pages: 123
The global Pharmaceutical Grade Methyl Isonicotinate market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-03
Pages: 113
The global Pharmaceutical Grade Methyl Isonicotinate market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-14
Pages: 71
The global market for Pharmaceutical Grade Methyl Isonicotinate was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-14
Pages: 80
In the field of medicine, methyl isonicotinate can be used as a strong vasodilator in the treatment of cardiovascular, bronchial and other diseases. It also has good antiviral activity and cancer cell inhibition, and can be used in the treatment of cancer and AIDS.
Published: 2024-04-14
Pages: 93
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now